| 5-FU | 5-fluorouracil |
| A2780 | human ovarian carcinoma cell line |
| ABCB1 | ATP binding cassette subfamily B member 1 |
| ABCC10 | ATP binding cassette subfamily C member 10 |
| Akt | serine/threonine-specific protein kinase |
| b.w. | body weight |
| Bak | pro-apoptotic Bcl-2 protein |
| Bax | bcl-2-like protein 4 |
| Bcl-2 | B-cell lymphoma 2 protein |
| BCR-ABL1 | breakpoint cluster region protein-Abelson murine leukemia viral oncogene homolog 1 |
| CDKI | cyclin-dependent kinase inhibitors |
| colon 205 | human Caucasian colon adenocarcinoma cell line |
| CoMFA | comparative molecular field analysis |
| CoMSIA | comparative molecular similarity index analysis |
| CYP | cytochrome P450 |
| DNA | deoxyribonucleic acid |
| EMA | European Medicines Agency |
| ERK | extracellular signal-regulated kinases |
| FAO | Food And Agriculture Organization |
| FDA | Food And Drug Administration |
| FGF | fibroblast growth factor |
| FLT3-ITD | fms-related tyrosine kinase 3 internal tandem duplication |
| HIF-1α | hypoxia-inducible factor 1-alpha |
| HMGB1 | high mobility group box 1 protein |
| IC50 | half maximal inhibitory concentration |
| MAPK | mitogen-activated protein kinase |
| Mcl-1 | induced myeloid leukemia cell differentiation protein |
| MDR | multidrug resistance |
| miRNA | micro-ribonucleic acid |
| MMP | matrix metalloproteinase |
| mRNA | messenger ribonucleic acid |
| Myc | proto-oncogene |
| nab-paclitaxel | nanoparticle albumin-bound paclitaxel |
| NF-κB | nuclear factor kappa B cells |
| Nrf2 | nuclear factor (erythroid-derived 2)-like 2 |
| P-388 | bipotential murine pre-B cell lymphoma |
| PEP005 | ingenol mebutate |
| PGDF | platelet-derived growth factor |
| P-gp | p-glycoprotein |
| PI3K | phosphatidylinositol-4,5-bisphosphate 3-kinase |
| PICN | paclitaxel injection concentrate for nanodispersion |
| PKC | protein kinase C |
| PKCα | protein kinase C-α |
| PKCδ | protein kinase C-δ |
| QSAR | quantitative structure activity relationship |
| RAID | rapid access to intervention in development |
| SAR | structure activity relationship |
| SCD-1 | stearoyl-CoA- desaturase 1 |
| SCLC | small-cell lung cancer |
| SIRT1 | NAD-dependent protein deacetylase sirtuin-1 |
| SM/Chol | sphingomyelin/cholesterol |
| smad3 | mothers against decapentaplegic homolog 3 |
| Sp1 | specificity protein 1 |
| STAT3 | signal transducer and activator of transcription 3 |
| T315I | mutation resulting in an amino acid substitution at position 315 in BCR-ABL1, from a threonine (T) to an isoleucine (I). |
| TGF-β | transforming growth factor beta |
| TRAIL | tumor necrosis factor-related apoptosis-inducing ligand |
| tRNA | transfer ribonucleic acid |
| uPAR | urokinase receptor |
| VEGF | vascular endothelial growth factor |
| WHO | World Health Organization |